VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Dopaminergic medication
Preclinical
Small molecule
U
Universidad Francisco de Vitoria
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Transcranial Direct Current Stimulation
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Transcranial Direct Current Stimulation
Preclinical
Completed
Clinical
Trials by Indication
[1]
Transcranial Direct Current Stimulation
1 trial
Transcranial Direct Current Stimulation for Treating Parkinson´s Disease-related Pain in OFF State
Completed
·
U
Universidad Francisco de Vitoria
·
N/A
·
NCT06214377
·
15 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Dopaminergic medication. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Dopaminergic medication compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Dopaminergic medication. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Universidad Francisco de Vitoria company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
U
Universidad Francisco de Vitoria
Related News